Table: Brightpath Biotherapeutics -2022/23 parent results

BrightPath Biotherapeutics Co

12/05/2023 07:05

May 12 (Reuters)- 
          Brightpath Biotherapeutics Co., Ltd. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended        Year to        NEXT   
              Mar 31, 2023    Mar 31, 2022    Mar 31, 2024      YEAR     
                 LATEST         YEAR-AGO         COMPANY       COMPANY   
                 RESULTS         RESULTS        FORECAST     H1 FORECAST 
  Sales           5 mln          15 mln           0 mln                  
               (-65.7 pct)    (+515.3 pct)    (-100.0 pct)               
  Operating     loss 1.47       loss 1.48       loss 1.35                
  Recurring     loss 1.47       loss 1.48       loss 1.35                
  Net           loss 1.49       loss 1.48       loss 1.36                
  EPS        loss 24.90 yen  loss 28.55 yen  loss 21.58 yen              
  Ann Div          NIL             NIL             NIL                   
  -Q2 Div          NIL             NIL             NIL                   
  -Q4 Div          NIL             NIL             NIL                   
  
  NOTE - Brightpath Biotherapeutics Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4594.T